Enhabit, INC 8-K filings

Enhabit, Inc. has been acquired by Kinderhook Industries for approximately $762 million, transitioning from a public company to a private entity.

Enhabit, Inc. announced that its stockholders have voted to adopt the Agreement and Plan of Merger, paving the way for the company's acquisition by Anchor Parent, LLC.

Enhabit, Inc. provides supplemental disclosures regarding its pending merger with Anchor Parent, LLC, addressing ongoing stockholder litigation and detailing the merger background.

Enhabit, Inc. received early termination of the HSR Act waiting period, moving closer to its acquisition by Kinderhook Industries.

Enhabit, Inc. announced the resignation of its Senior Vice President and Chief Accounting Officer, Collin McQuiddy, effective March 27, 2026, with CFO Ryan Solomon assuming interim duties.

Enhabit, Inc. has entered into a definitive agreement to be acquired by Kinderhook Industries, LLC in an all-cash transaction valued at approximately $1.1 billion.

Enhabit, Inc. and Encompass Health Corporation have collected $43.1 million in settlement of claims from a Delaware fiduciary breach lawsuit, also securing a constructive trust for future profits.

Enhabit, Inc. provides an update on its 2026 pricing impacts, strategic growth plans, and reiterates 2025 financial guidance at the BofA Securities Home Care Conference.

Enhabit, Inc. reports robust third-quarter 2025 results with significant year-over-year growth in revenue and Adjusted EBITDA, alongside continued debt reduction and an updated positive full-year guidance.

Enhabit, Inc. highlights Q2 2025 financial improvements, significant debt reduction, and strong hospice growth while addressing home health industry pressures.

Enhabit, Inc. reports strong second quarter 2025 financial results with sequential and year-over-year growth in revenue and Adjusted EBITDA, leading to increased full-year guidance.

Enhabit, Inc. announced CEO Barbara Jacobsmeyer's planned departure by July 2026 and granted retention awards totaling over $1.9 million to key executives to ensure leadership stability.

Enhabit, Inc. stockholders approved the 2025 Equity and Incentive Compensation Plan and re-elected all nominated directors at the Annual Meeting held on June 26, 2025.

Enhabit Home Health & Hospice presented its Q1 2025 highlights, strategic priorities, and strong hospice growth momentum at the Goldman Sachs 46th Annual Global Healthcare Conference.

Enhabit, Inc. reports a successful first quarter in 2025, driven by census growth in both home health and hospice segments, improved profitability, and balance sheet improvements.

Enhabit, Inc. has sold its investment interest in Medalogix for approximately $21 million and intends to use the proceeds to reduce debt.

Enhabit reports a net loss for Q4 2024 but shows growth in hospice and non-Medicare home health segments, issuing full-year 2025 guidance with revenue between $1.05 billion and $1.08 billion.

Enhabit, Inc. announces the nomination of Stephan Rodgers, former CEO of AccentCare, to its board of directors at the 2025 annual meeting of stockholders.

Enhabit, Inc. has reached a new multi-year agreement with UnitedHealthcare, ensuring continued access for UHC members to Enhabit's home health services, and provided an update on anticipated pricing impacts for 2025.

Encompass Health and Enhabit secured a legal victory, winning a lawsuit against former officers and private equity firms for breaches of fiduciary duty, resulting in a 43% stake in the competitor's profits and exit proceeds.

Enhabit, Inc. has announced the appointment of Ryan Solomon as its new Chief Financial Officer, effective December 9, 2024, bringing extensive experience in the home health and hospice sector.

Enhabit's third quarter results show a net loss of $110.2 million, but adjusted EBITDA grew by 5.6% year-over-year, driven by hospice revenue and cost reductions.

Enhabit, Inc. has appointed Collin McQuiddy as Senior Vice President and Chief Accounting Officer, effective August 5, 2024.

Enhabit, Inc. announced that its Chief Financial Officer, Crissy Carlisle, will step down from her role, with a transition period planned until December 31, 2024, or an earlier date.

Enhabit's second quarter results show a mixed performance with strong non-Medicare admissions growth offsetting a decline in Medicare revenue, while the company updates its full-year guidance.

Enhabit, Inc. held its 2024 Annual Meeting of Stockholders, electing directors and ratifying the appointment of PricewaterhouseCoopers LLP as its independent accounting firm.

Enhabit has announced the preliminary results of its 2024 Annual Meeting of Stockholders, indicating the election of eight company-nominated directors and one nominee from AREX Capital Management.

Enhabit released preliminary second quarter 2024 results, indicating continued business stabilization with improved operational performance and debt reduction.

Enhabit presented its growth strategy focusing on home health and hospice services at the Goldman Sachs 45th Annual Global Healthcare Conference.

Enhabit's Board of Directors has concluded its strategic review process, deciding to continue operating as an independent public company.